4.6 Article

Anticancer activity and toxicity profiles of 2-benzylidene indanone lead molecule

期刊

出版社

ELSEVIER SCIENCE BV
DOI: 10.1016/j.ejps.2015.04.020

关键词

Benzylidene indanone; Anticancer; Cell cycle; Caspase; Sub-acute toxicity; Ehrlich ascites carcinoma

资金

  1. SERB-DST

向作者/读者索取更多资源

3-(3',4',5'-Trimethoxyphenyl)-4,5,6-trimethoxy,2-(3 '',4 ''-methylenedioxybenzylidene)-indan-1 -one (1) is an optimized anti-cancer lead molecule obtained on modification of gallic acid, a plant phenolic acid. It exhibited potent cytotoxicities (IC50 = 0.010-14.76 mu M) against various human carcinoma cells. In cell cycle analysis, benzylidene indanone 1 induced G2/M phase arrest in both MCF-7 and MDA-MB-231 cells. It also induced apoptosis in DU145 cells which was evident by cleavage of PARP. In Ehrlich ascites carcinoma, benzylidene indanone 1 showed 45.48% inhibition of tumour growth at 20 mg/kg dose in Swiss albino mice. Further, in sub-acute toxicity experiment in Swiss-albino mice, it was found to be non-toxic up to 100 mg/kg dose for 28 days. The lead compound benzylidene indanone 1 can further be optimized for better anti-cancer activity. (C) 2015 Elsevier B.V. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Gastroenterology & Hepatology

Evidence for the presence and release of BDNF in the neuronal and non-neuronal structures of the internal anal sphincter

Arjun Singh, Jagmohan Singh, Satish Rattan

Summary: Background data on the neuromodulatory effects of brain-derived neurotrophic factor (BDNF) in the gastrointestinal tract have been reported, but there is still a lack of data on the presence, distribution, and release of BDNF in the gastrointestinal tract, including the internal anal sphincter (IAS). The study found that BDNF/TrkB is present not only in the enteric nervous system (ENS), but also in the smooth muscle cells (SMCs). BDNF is released locally from the ENS (myenteric and submucosal plexus) and the SMCs, which has implications for IAS-related rectoanal motility disorders.

NEUROGASTROENTEROLOGY AND MOTILITY (2022)

Article Peripheral Vascular Disease

Inhibition of Mitogen-Activated Protein Kinase (MAPK)-Activated Protein Kinase 2 (MK2) is Protective in Pulmonary Hypertension

Mohammad Shafid, Kumaravelu Jagavelu, Hina Iqbal, Pankaj Yadav, Debabrata Chanda, Neeraj Kumar Verma, Jimut Kanti Ghosh, Matthias Gaestel, Kashif Hanif

Summary: MK2 plays a significant role in pulmonary hypertension, and its inhibition may be a novel target for PH treatment. Inhibition of MK2 alleviated right ventricle pressure and hypertrophy in PH rats, improved cardiac function, reversed pulmonary vascular remodeling, and enhanced pulmonary vascular relaxation.

HYPERTENSION (2021)

Article Biochemistry & Molecular Biology

A rohitukine derivative IIIM-290 induces p53 dependent mitochondrial apoptosis in acute lymphoblastic leukemia cells

Mubashir Mintoo, Sameer Khan, Abubakar Wani, Sumera Malik, Deendyal Bhurta, Sandip Bharate, Fayaz Malik, Dilip Mondhe

Summary: The study reveals that IIIM-290 induces apoptosis in MOLT-4 cells by upregulating various apoptotic proteins, and shows promising anticancer potential in murine leukemic tumor models.

MOLECULAR CARCINOGENESIS (2021)

Article Pharmacology & Pharmacy

2-Benzyllawsone protects against polymicrobial sepsis and vascular hyporeactivity in swiss albino mice

Pankaj Yadav, Hina Iqbal, Kapil Kumar, Parmanand Kumar, Divya Mishra, Arjun Singh, Anirban Pal, Pradipto Mukhopadhyay, Beena Vamadevan, Dhirendra Singh, Arvind Singh Negi, Debabrata Chanda

Summary: LT-9 exhibited potent biological activity against sepsis in CLP mice by reversing vascular hyporeactivity and enhancing contraction response to norepinephrine through opening of L-type VDCC. Oral administration of LT-9 for 15 days significantly improved survival time, hemodynamic and ECG profile in CLP mice.

EUROPEAN JOURNAL OF PHARMACOLOGY (2022)

Article Medicine, Research & Experimental

Codelivery of Gemcitabine and MUC1 Inhibitor Using PEG-PCL Nanoparticles for Breast Cancer Therapy

Akanksha Behl, Parul Sarwalia, Sushil Kumar, Chittaranjan Behera, Mubashir Javed Mintoo, Tirtha Kumar Datta, Prem N. Gupta, Anil K. Chhillar

Summary: The synergistic potential of MUC1 inhibitors and Gemcitabine-loaded nanoparticles was discussed in this study, aiming to enhance the therapeutic efficacy. Gemcitabine and MUC1 inhibitors were loaded into polymeric nanoparticles using the double emulsion solvent evaporation method. The results showed that the twin-loaded nanoparticles exhibited better anticancer effects.

MOLECULAR PHARMACEUTICS (2022)

Article Multidisciplinary Sciences

Activation of lysosomal mediated cell death in the course of autophagy by mTORC1 inhibitor

Sameer Ullah Khan, Anup Singh Pathania, Abubakar Wani, Kaneez Fatima, Mubashir Javed Mintoo, Baseerat Hamza, Masroor Ahmad Paddar, Wadhwa Bhumika, Loveleena Kour Anand, Mir Shahid Maqbool, Sameer Ahmad Mir, Jaspreet Kour, Vunnam Venkateswarlu, Dilip Manikrao Mondhe, Sanghapal D. Sawant, Fayaz Malik

Summary: Lysosomal biogenesis plays a vital role in determining cell fate, but excessive biogenesis can lead to cell death. In pancreatic cancer cells, dysregulation of apoptosis allows the cells to evade cell death. However, a study has shown that treatment with SDS-203 triggers non-apoptotic cell death by causing an overaccumulation of lysosomes. This finding suggests that targeting lysosomal biogenesis could be a potential therapeutic approach for pancreatic cancer.

SCIENTIFIC REPORTS (2022)

Correction Multidisciplinary Sciences

Activation of lysosomal mediated cell death in the course of autophagy by mTORC1 inhibitor (vol 12, 5052, 2022)

Sameer Ullah Khan, Anup Singh Pathania, Abubakar Wani, Kaneez Fatima, Mubashir Javed Mintoo, Baseerat Hamza, Masroor Ahmad Paddar, Wadhwa Bhumika, Loveleena Kour Anand, Mir Shahid Maqbool, Sameer Ahmad Mir, Jaspreet Kour, Vunnam Venkateswarlu, Dilip Manikrao Mondhe, Sanghapal D. Sawant, Fayaz Malik

SCIENTIFIC REPORTS (2022)

Article Endocrinology & Metabolism

MiR-539-3p impairs osteogenesis by suppressing Wnt interaction with LRP-6 co-receptor and subsequent inhibition of Akap-3 signaling pathway

Alok Tripathi, Aijaz A. John, Deepak Kumar, Saurabh Kumar Kaushal, Devendra Pratap Singh, Nazim Husain, Jayanta Sarkar, Divya Singh

Summary: This study reports the functional role of miR-539-3p in osteoblast functions and its downstream Akap-3 signaling in the regulation of osteoblastogenesis.

FRONTIERS IN ENDOCRINOLOGY (2022)

Article Integrative & Complementary Medicine

In vitro and in vivo anticancer potential and molecular targets of the new colchicine analog IIIM-067

Sumera Malik, Mubashir J. Mintoo, Chilakala Nagarjuna Reddy, Rajesh Kumar, Pankul Kotwal, Sandip B. Bharate, Utpal Nandi, Dilip M. Mondhe, Sanket K. Shukla

Summary: The study evaluated new colchicine analogs for their anticancer activity and determined their mechanism of action and in vivo efficacy. IIIM-067 showed potent cytotoxicity and better selectivity than other analogs. It reduced clonogenicity and induced apoptosis in A549 cells, as well as showed promising anticancer activity in vivo.

JOURNAL OF INTEGRATIVE MEDICINE-JIM (2023)

Article Cell Biology

Inhibition of p21 activates Akt kinase to trigger ROS-induced autophagy and impacts on tumor growth rate

Mayank Maheshwari, Nisha Yadav, Mohammad Hasanain, Praveen Pandey, Rohit Sahai, Kuldeep Choyal, Akhilesh Singh, Mushtaq A. Nengroo, Krishan K. Saini, Deepak Kumar, Kalyan Mitra, Dipak Datta, Jayanta Sarkar

Summary: The article discusses the dual function of p21 in cancer, with both inhibitory and oncogenic effects. Specifically, p21 negatively regulates basal autophagy and has oncogenic activity during early tumor development, while its inhibition promotes survival and growth of established tumors.

CELL DEATH & DISEASE (2022)

Article Oncology

LZTR1 Mutation Mediates Oncogenesis through Stabilization of EGFR and AXL

Aram Ko, Mohammad Hasanain, Young Taek Oh, Fulvio D'Angelo, Danika Sommer, Brulinda Frangaj, Suzanne Tran, Franck Bielle, Bianca Pollo, Rosina Paterra, Karima Mokhtari, Rajesh Kumar Soni, Matthieu Peyre, Marica Eoli, Laura Papi, Michel Kalamarides, Marc Sanson, Antonio Iavarone, Anna Lasorella

Summary: LZTR1 is a substrate-specific adaptor of a CUL3-dependent ubiquitin ligase frequently mutated in cancer. The study identified EGFR and AXL as LZTR1 substrates targeted for degradation, and found that LZTR1 mutations result in the accumulation and deregulated signaling of EGFR and AXL. The study also revealed vulnerabilities of LZTR1-mutant tumors to inhibition of EGFR and AXL, providing precision targeting for patients with LZTR1-mutant cancer.

CANCER DISCOVERY (2023)

Article Oncology

Integrative multi-omics networks identify PKCδ and DNA-PK as master kinases of glioblastoma subtypes and guide targeted cancer therapy

Simona Migliozzi, Young Taek Oh, Mohammad Hasanain, Luciano Garofano, Fulvio D'Angelo, Ryan D. Najac, Alberto Picca, Franck Bielle, Anna Luisa Di Stefano, Julie Lerond, Jann N. Sarkaria, Michele Ceccarelli, Marc Sanson, Anna Lasorella, Antonio Iavarone

Summary: Proteogenomic characterization of human tumors has identified master kinases that play key roles in functional subtypes of glioblastoma. These master kinases have potential as subtype-specific therapeutic targets and can be used to inform patient selection in clinical trials. The researchers have also developed a classification tool that evaluates therapeutic response and subtype association in glioblastoma.

NATURE CANCER (2023)

Article Agricultural Engineering

Potential lipase inhibitor from underutilized part of Andrographis paniculata: Targeted isolation and mechanism of inhibition

Pooja Gaur, Feroz Khan, Karuna Shanker

Summary: This study successfully isolated biologically active compounds from Andrographis paniculata root that have the ability to absorb dietary fat, making them potential candidates for obesity management. 7-O-methyl-dihydro wogonin (MDHW) exhibited the strongest pancreatic lipase inhibition activity and showed a synergistic effect with orlistat. MDHW acts as a competitive inhibitor through energy transfer from pancreatic lipase, and the binding interaction between MDHW and pancreatic lipase is hydrophobic. In vitro and in silico studies confirmed the potential of MDHW as an anti-obesity agent for pharmaceutical and food industry applications.

INDUSTRIAL CROPS AND PRODUCTS (2023)

Article Chemistry, Analytical

Validation and greenness assessment of HPTLC-densitometric method for simultaneous estimation of six bioactive alkamides in Piper longum Linn. root

Pooja Gaur, Princi Gupta, Neerja Tiwari, Namita Gupta, Karuna Shanker

Summary: A novel HPTLC method was developed for the simultaneous quantification of six bioactive alkaloids in agro-waste of Piper longum. The method demonstrated excellent separation and specificity, and was successfully applied for accurate quantification in Piper longum roots. Additionally, the method was found to be environmentally friendly and energy efficient.

MICROCHEMICAL JOURNAL (2023)

Article Agriculture, Multidisciplinary

Utilization of Agro-Waste of Piper longum for a Potential Pancreatic Lipase Inhibitor

Pooja Gaur, Neerja Tiwari, Karuna Shanker

Summary: This study demonstrates the potential of using agricultural wastes of Piper longum as antiobesity agents through the extraction of pseudoalkaloids. One of the compounds, pellitorine, showed strong pancreatic lipase inhibitory activity and exhibited synergistic effects with orlistat. The structural compactness of the interaction between pellitorine and pancreatic lipase was confirmed by Fourier transform infrared spectral studies. Molecular docking studies further revealed the binding interaction between pellitorine and the catalytic active amino side residue of the protein. These findings suggest that pellitorine has the potential to be developed as an anti-obesity supplement.

ACS AGRICULTURAL SCIENCE & TECHNOLOGY (2022)

Article Pharmacology & Pharmacy

Analysis of stabilization mechanisms in β-lactoglobulin-based amorphous solid dispersions by experimental and computational approaches

Xuezhi Zhuo, Vito Fodera, Per Larsson, Zarah Schaal, Christel A. S. Bergstrom, Korbinian Lobmann, Aleksei Kabedev

Summary: Our previous work demonstrated that beta-lactoglobulin-stabilized amorphous solid dispersion (ASD) loaded with 70 % indomethacin remains stable for over 12 months. We further investigated the stabilization mechanisms by testing five other drug molecules and using experimental techniques and molecular dynamics simulations. The results showed that steric confinement, hydrogen bonding, and the glass transition temperature of the drug molecule play important roles in stabilizing ASDs with high drug loadings.

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2024)

Article Pharmacology & Pharmacy

Do the enantiomers of ketamine bind enantioselectively to human serum albumin?

Sebastian Schmidt, Ulrike Holzgrabe

Summary: The binding of drugs to plasma proteins, such as human serum albumin (HSA), is crucial for determining pharmacokinetic parameters. This study investigated the enantioselective binding of S- and R-ketamine to HSA. It was found that ketamine has weak affinity to HSA, with no significant differences in binding behavior between the individual enantiomers and the racemate. The aromatic ring and N-methyl group were identified as the most strongly involved structural moieties in the binding of ketamine to HSA.

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2024)

Article Pharmacology & Pharmacy

Targeting fusion proteins of the interleukin family: A promising new strategy for the treatment of autoinflammatory diseases

Yuchen Zhao, Han Wang, Lin Jin, Ziwei Zhang, Lianghu Liu, Mengqi Zhou, Xianzheng Zhang, Lingling Zhang

Summary: Interleukins (ILs) are important for communication between immune cells and non-immune cells, but dysregulation of ILs expression is a characteristic of autoinflammatory diseases. Drugs targeting ILs have significant clinical benefits, but may also cause adverse reactions. Fusion protein technology, with its ability to enhance therapeutic efficacy, has been explored for developing anti-inflammatory drugs. This review discusses the efficacy of fusion protein drugs developed with ILs or their receptors in treating autoinflammatory diseases, highlighting the potential of this technology in future anti-inflammatory drug development.

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2024)

Article Pharmacology & Pharmacy

The use of polymorphic state modifiers in solid lipid microparticles: The role of structural modifications on drug release performance

Serena Bertoni, Elena Simone, Stefano Sangiorgi, Beatrice Albertini, Nadia Passerini

Summary: This study investigated the correlation between the structure and release properties of solid lipid microparticles (MPs) with different liquid additives. The additives accelerated the conversion of the unstable alpha-form of tristearin to the stable beta-polymorph and caused structural modifications in the MPs. The presence of additives prolonged the drug release in water and resulted in higher release profiles in biorelevant media. The findings suggest that the release behavior can be influenced by the polymorphism and supramolecular-level structural modification of lipid formulations containing crystal modifiers.

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2024)

Article Pharmacology & Pharmacy

Altering distribution profile of palbociclib by its prodrugs

Juulia Jarvinen, Ahmed B. Montaser, Santosh Kumar Adla, Jukka Leppanen, Marko Lehtonen, Kati-Sisko Vellonen, Tuomo Laitinen, Aaro Jalkanen, William F. Elmquist, Juri Timonen, Kristiina M. Huttunen, Jarkko Rautio

Summary: This study attempted to alter the brain distribution pattern of Palbociclib by creating and assessing two novel prodrugs. Although the prodrug design did not significantly improve Palbociclib brain delivery, the study provides valuable insights for future prodrug development and drug delivery strategies targeting specific transporters.

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2024)

Review Pharmacology & Pharmacy

The prescription design and key properties of nasal gel for CNS drug delivery: A review

Miao Wang, Xinyu Ma, Shiyu Zong, Yaqiong Su, Rui Su, Hong Zhang, Yang Liu, Chunliu Wang, Ye Li

Summary: This article discusses the potential and limitations of nasal administration in central nervous system drug delivery. Nasal gel viscosity can alleviate the impact of nasal mucociliary clearance on drug delivery, and materials such as gellan gum, chitosan, carbomer, cellulose, and poloxamer can be used to prepare nasal gels.

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2024)

Article Pharmacology & Pharmacy

Impact of drug load and polymer molecular weight on the 3D microstructure of printed tablets

Bjarke Strom Larsen, Eric Kissi, Liebert Parreiras Nogueira, Natalja Genina, Ingunn Tho

Summary: This study investigates the influence of drug load and polymer molecular weight on the structure of 3D printed tablets. The results show that drug load and polymer molecular weight have a significant impact on the porosity and size of the tablets, while the effect of drug load on the total porosity of the tablets is minimal.

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2024)

Article Pharmacology & Pharmacy

Ultrasound-guided periadventitial administration of rapamycin-fibrin glue attenuates neointimal hyperplasia in the rat carotid artery injury model

Zhentao Qiao, Fuhang Wang, Dongjian Han, Yuansong Zhuang, Qingjiao Jiang, Yi Zhang, Miaomiao Liu, Quanxu An, Zhiwei Wang, Deliang Shen

Summary: In this study, it was demonstrated that periadventitial delivery of rapamycin-fibrin glue (RPM-FG) can inhibit intimal hyperplasia (IH) in a rat carotid artery injury model without compromising re-endothelialization. This provides a promising direction for the future development of a safe, effective, and minimally invasive perivascular drug delivery method to treat vascular disease.

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2024)

Article Pharmacology & Pharmacy

Designing greener active pharmaceutical ingredients: Insights from pharmaceutical industry into drug discovery and development

Neele Puhlmann, Rodrigo Vidaurre, Klaus Kuemmerer

Summary: Active pharmaceutical ingredients and their metabolites and transformation products are pollutants that can harm human and environmental health. Designing greener APIs is an effective strategy to address this issue. The drug discovery and development process can incorporate environmental parameters to achieve this design, and this process is highly flexible.

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2024)